OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 148 filers reported holding OCULAR THERAPEUTIX INC in Q2 2024. The put-call ratio across all filers is 3.05 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $7,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | +40.0% | 1,100 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | +400.0% | 1,100 | +1000.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -80.0% | 100 | -80.0% | 0.00% | – |
| Q1 2017 | $5,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $11,567,000 | 57.21% |
| Opaleye Management Inc. | 2,775,000 | $8,436,000 | 3.05% |
| Versant Venture Management, LLC | 2,215,384 | $6,734,767,000 | 2.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,008,484 | $6,106,000 | 1.54% |
| SV Health Investors, LLC | 628,236 | $1,910,000 | 1.34% |
| NOTTINGHAM ADVISORS, INC. | 195,766 | $595,000 | 0.08% |
| MYCIO WEALTH PARTNERS, LLC | 267,340 | $813,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 90,527 | $275,000 | 0.02% |
| Man Group plc | 1,909,478 | $5,805,000 | 0.02% |
| MERCER GLOBAL ADVISORS INC /ADV | 95,837 | $291,000 | 0.01% |